|
| |
Relora Max is a natural proprietary blend of a patented extract of Magnolia officinalis and a proprietary extract from Phellodendron amurense. Relora was developed as an ingredient for dietary supplements and functional foods that could be used in stress management and for stress-related appetite control. This patented blend of plant extracts is the result of screening more than fifty plant fractions from traditional plant medicines used around the world. Relora® has excellent stress management properties without causing sedation.
Relora Max is a natural stress management ingredient that helps control stress-related eating and has the added value of being non-sedating. In central nervous system receptor binding assays the plant extracts in Relora binds to several important targets associated with stress. It does not bind to the benzodiazepine receptors that would cause sedation, yet has the relaxing qualities
that have been demonstrated in both animal and human studies. In addition, it normalizes hormone levels associated with stress-induced weight gain and eating behavior. Stress has been shown to play a significant role in a variety of conditions. A large percentage of overweight adults have excessive abdominal fat due to stress-related over eating. Relora appears to maintain healthy hormone levels in stressed individuals and act as an aid in controlling weight and stress-related eating.
8 out of 10 people feel more relaxed
Relora helps control stress-related symptoms, such as: irritability; emotional ups and downs; restlessness; tense muscles; poor sleep; concentration difficulties. Post trial analysis revealed an excellent agreement with the pretrial concept. In addition, Relora® reduced stress-related snacking of sweets, such as ice cream, cake, pie, and cookies by 76% in those individuals that claimed they ate these types of foods under stress.
|
|
BACK TO TOP
Clinical Trial
A double-blind placebo-controlled clinical trial with Relora was completed in January 2004. The purpose of this study was to determine the effects of Relora® in overweight women who typically eat more in stressful situations. Twenty-eight subjects completed the study and Relora® was well tolerated. There was a significant weight gain during the study for the placebo group but no significant weight gain and some weight loss for the Relora® group. There was also a significant reduction in anxiety scores. The mechanism of action appears to be through reduction or normalization of stress hormone levels, and possibly perceived stress, thereby helping subjects maintain body weight.
BACK TO TOP
|
|
